{
    "info": {
        "nct_id": "NCT03281382",
        "official_title": "PHASE 1 TRIAL OF ONCOLYTIC ADENOVIRUS-MEDIATED CYTOTOXIC AND IL-12 GENE THERAPY IN COMBINATION WITH CHEMOTHERAPY FOR THE TREATMENT OF METASTATIC PANCREATIC CANCER",
        "inclusion_criteria": "* Histologically proven (biopsy or cytology) metastatic pancreatic adenocarcinoma.\n* Age ≥ 18 years.\n* No prior treatment (surgery, chemotherapy, radiotherapy, or biological therapy) for the study cancer.\n* Zubrod performance score of 0 - 2 within 30 days of registration.\n* Subjects must have adequate baseline organ function, as assessed by the following laboratory values, within 30 days before initiating the study therapy:\n\n  * Adequate renal function with serum creatinine ≤ 1.8 mg/dL or creatinine clearance ≥ 50 mL/min/m2.\n  * Absolute neutrophil count > 1,000/μL.\n  * Hemoglobin > 8.0 g/dL.\n  * Platelet count > 100,000/μL.\n  * Bilirubin < 2.0 mg/dL.\n  * SGOT and SGPT < 3.0 times upper limit of normal (ULN). Subjects with liver metastases may have SGOT/SGPT < 5.0 times ULN.\n* Women of childbearing potential and male participants must agree to use a medically effective means of birth control throughout and for 60 days beyond the treatment phase of the study.\n* Subjects on oral warfarin anticoagulation therapy may be included in this study, but must have close monitoring of their coagulation parameters as altered parameters and/or bleeding have been reported in patients taking Xeloda® and such agents concomitantly. Subjects on other forms of anti-coagulation therapies may need close clinical monitoring for signs or symptoms of bleeding.\n* The subject must possess the ability to give informed consent and express a willingness to meet all of the expected requirements of the protocol for the duration of the study.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Pregnant and lactating women.\n* Clinical or laboratory evidence of pancreatitis, based on discretion of treating physician.\n* Serious non-malignant disease (e.g., congestive heart failure or uncontrolled infections), which, in the opinion of the investigator would compromise study objectives.\n* Major surgery planned within 3 months of registration other than diagnostic procedures such as laparoscopy or endoscopic ultrasound and stenting or PEG/PEJ placement.\n* Islet cell tumor, benign cyst, peri-ampullary carcinoma or any non-adenocarcinomas.\n* Acute infection. Acute infection is defined by any viral, bacterial, or fungal infection that has required specific therapy within 72 hours of initiation of the study therapy (defined as day 1).\n* Previous history of liver disease including hepatitis.\n* Positive serologic test for Hepatitis B or C at baseline.\n* Immunosuppressive therapy including systemic corticosteroids. Use of inhaled and topical corticosteroids is permitted.\n* Impaired immunity or susceptibility to serious viral infections.\n* Allergy to any product used on the protocol.\n* Serious medical or psychiatric illness or concomitant medication, which, in the judgment of the investigator, might interfere with the subject's ability to respond to or tolerate the treatment or complete the trial.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Adequate renal function with serum creatinine ≤ 1.8 mg/dL or creatinine clearance ≥ 50 mL/min/m2.",
            "criterions": [
                {
                    "exact_snippets": "Adequate renal function with serum creatinine ≤ 1.8 mg/dL",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.8,
                                "unit": "mg/dL"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "creatinine clearance ≥ 50 mL/min/m2",
                    "criterion": "creatinine clearance",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50,
                                "unit": "mL/min/m2"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Zubrod performance score of 0 - 2 within 30 days of registration.",
            "criterions": [
                {
                    "exact_snippets": "Zubrod performance score of 0 - 2",
                    "criterion": "Zubrod performance score",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "within 30 days of registration",
                    "criterion": "assessment timing",
                    "requirements": [
                        {
                            "requirement_type": "time window",
                            "expected_value": "within 30 days of registration"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects on oral warfarin anticoagulation therapy may be included in this study, but must have close monitoring of their coagulation parameters as altered parameters and/or bleeding have been reported in patients taking Xeloda® and such agents concomitantly. Subjects on other forms of anti-coagulation therapies may need close clinical monitoring for signs or symptoms of bleeding.",
            "criterions": [
                {
                    "exact_snippets": "Subjects on oral warfarin anticoagulation therapy may be included ... must have close monitoring of their coagulation parameters",
                    "criterion": "oral warfarin anticoagulation therapy",
                    "requirements": [
                        {
                            "requirement_type": "current therapy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "monitoring of coagulation parameters",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Subjects on other forms of anti-coagulation therapies may need close clinical monitoring for signs or symptoms of bleeding",
                    "criterion": "other forms of anti-coagulation therapies",
                    "requirements": [
                        {
                            "requirement_type": "current therapy",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "clinical monitoring for signs or symptoms of bleeding",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* No prior treatment (surgery, chemotherapy, radiotherapy, or biological therapy) for the study cancer.",
            "criterions": [
                {
                    "exact_snippets": "No prior treatment (surgery, chemotherapy, radiotherapy, or biological therapy) for the study cancer.",
                    "criterion": "prior treatment for the study cancer",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "treatment_types",
                            "expected_value": [
                                "surgery",
                                "chemotherapy",
                                "radiotherapy",
                                "biological therapy"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Histologically proven (biopsy or cytology) metastatic pancreatic adenocarcinoma.",
            "criterions": [
                {
                    "exact_snippets": "Histologically proven (biopsy or cytology)",
                    "criterion": "pancreatic adenocarcinoma",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_method",
                            "expected_value": [
                                "histology",
                                "biopsy",
                                "cytology"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "metastatic pancreatic adenocarcinoma",
                    "criterion": "pancreatic adenocarcinoma",
                    "requirements": [
                        {
                            "requirement_type": "metastatic_status",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Women of childbearing potential and male participants must agree to use a medically effective means of birth control throughout and for 60 days beyond the treatment phase of the study.",
            "criterions": [
                {
                    "exact_snippets": "Women of childbearing potential and male participants must agree to use a medically effective means of birth control throughout and for 60 days beyond the treatment phase of the study.",
                    "criterion": "use of medically effective birth control",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "throughout and for 60 days beyond the treatment phase of the study"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* The subject must possess the ability to give informed consent and express a willingness to meet all of the expected requirements of the protocol for the duration of the study.",
            "criterions": [
                {
                    "exact_snippets": "possess the ability to give informed consent",
                    "criterion": "ability to give informed consent",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "express a willingness to meet all of the expected requirements of the protocol for the duration of the study",
                    "criterion": "willingness to comply with protocol requirements",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Subjects must have adequate baseline organ function, as assessed by the following laboratory values, within 30 days before initiating the study therapy:",
            "criterions": [
                {
                    "exact_snippets": "adequate baseline organ function",
                    "criterion": "baseline organ function",
                    "requirements": [
                        {
                            "requirement_type": "adequacy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Bilirubin < 2.0 mg/dL.",
            "criterions": [
                {
                    "exact_snippets": "Bilirubin < 2.0 mg/dL",
                    "criterion": "bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 2.0,
                                "unit": "mg/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age ≥ 18 years.",
            "criterions": [
                {
                    "exact_snippets": "Age ≥ 18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Absolute neutrophil count > 1,000/μL.",
            "criterions": [
                {
                    "exact_snippets": "Absolute neutrophil count > 1,000/μL.",
                    "criterion": "absolute neutrophil count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 1000,
                                "unit": "/μL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hemoglobin > 8.0 g/dL.",
            "criterions": [
                {
                    "exact_snippets": "Hemoglobin > 8.0 g/dL",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 8.0,
                                "unit": "g/dL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Platelet count > 100,000/μL.",
            "criterions": [
                {
                    "exact_snippets": "Platelet count > 100,000/μL",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 100000,
                                "unit": "/μL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* SGOT and SGPT < 3.0 times upper limit of normal (ULN). Subjects with liver metastases may have SGOT/SGPT < 5.0 times ULN.",
            "criterions": [
                {
                    "exact_snippets": "SGOT and SGPT < 3.0 times upper limit of normal (ULN)",
                    "criterion": "SGOT",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 3.0,
                                "unit": "times ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "SGOT and SGPT < 3.0 times upper limit of normal (ULN)",
                    "criterion": "SGPT",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 3.0,
                                "unit": "times ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Subjects with liver metastases may have SGOT/SGPT < 5.0 times ULN",
                    "criterion": "SGOT (in subjects with liver metastases)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 5.0,
                                "unit": "times ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Subjects with liver metastases may have SGOT/SGPT < 5.0 times ULN",
                    "criterion": "SGPT (in subjects with liver metastases)",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 5.0,
                                "unit": "times ULN"
                            }
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Pregnant and lactating women.",
            "criterions": [
                {
                    "exact_snippets": "Pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "lactating women",
                    "criterion": "lactation status",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Immunosuppressive therapy including systemic corticosteroids. Use of inhaled and topical corticosteroids is permitted.",
            "criterions": [
                {
                    "exact_snippets": "Immunosuppressive therapy including systemic corticosteroids",
                    "criterion": "immunosuppressive therapy",
                    "requirements": [
                        {
                            "requirement_type": "use",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Use of inhaled and topical corticosteroids is permitted",
                    "criterion": "inhaled and topical corticosteroids",
                    "requirements": [
                        {
                            "requirement_type": "use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serious non-malignant disease (e.g., congestive heart failure or uncontrolled infections), which, in the opinion of the investigator would compromise study objectives.",
            "criterions": [
                {
                    "exact_snippets": "Serious non-malignant disease (e.g., congestive heart failure or uncontrolled infections)",
                    "criterion": "serious non-malignant disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Impaired immunity or susceptibility to serious viral infections.",
            "criterions": [
                {
                    "exact_snippets": "Impaired immunity",
                    "criterion": "immunity",
                    "requirements": [
                        {
                            "requirement_type": "impairment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "susceptibility to serious viral infections",
                    "criterion": "susceptibility to serious viral infections",
                    "requirements": [
                        {
                            "requirement_type": "susceptibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Islet cell tumor, benign cyst, peri-ampullary carcinoma or any non-adenocarcinomas.",
            "criterions": [
                {
                    "exact_snippets": "Islet cell tumor",
                    "criterion": "islet cell tumor",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "benign cyst",
                    "criterion": "benign cyst",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "peri-ampullary carcinoma",
                    "criterion": "peri-ampullary carcinoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "any non-adenocarcinomas",
                    "criterion": "non-adenocarcinoma",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Acute infection. Acute infection is defined by any viral, bacterial, or fungal infection that has required specific therapy within 72 hours of initiation of the study therapy (defined as day 1).",
            "criterions": [
                {
                    "exact_snippets": "Acute infection. Acute infection is defined by any viral, bacterial, or fungal infection that has required specific therapy within 72 hours of initiation of the study therapy (defined as day 1).",
                    "criterion": "acute infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "type",
                            "expected_value": [
                                "viral",
                                "bacterial",
                                "fungal"
                            ]
                        },
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "treatment timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 72,
                                "unit": "hours before day 1"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serious medical or psychiatric illness or concomitant medication, which, in the judgment of the investigator, might interfere with the subject's ability to respond to or tolerate the treatment or complete the trial.",
            "criterions": [
                {
                    "exact_snippets": "Serious medical or psychiatric illness ... might interfere with the subject's ability to respond to or tolerate the treatment or complete the trial.",
                    "criterion": "serious medical or psychiatric illness",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "concomitant medication ... might interfere with the subject's ability to respond to or tolerate the treatment or complete the trial.",
                    "criterion": "concomitant medication",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Previous history of liver disease including hepatitis.",
            "criterions": [
                {
                    "exact_snippets": "Previous history of liver disease",
                    "criterion": "liver disease",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "including hepatitis",
                    "criterion": "hepatitis",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Allergy to any product used on the protocol.",
            "criterions": [
                {
                    "exact_snippets": "Allergy to any product used on the protocol",
                    "criterion": "allergy to protocol product",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Major surgery planned within 3 months of registration other than diagnostic procedures such as laparoscopy or endoscopic ultrasound and stenting or PEG/PEJ placement.",
            "criterions": [
                {
                    "exact_snippets": "Major surgery planned within 3 months of registration other than diagnostic procedures such as laparoscopy or endoscopic ultrasound and stenting or PEG/PEJ placement.",
                    "criterion": "major surgery",
                    "requirements": [
                        {
                            "requirement_type": "planned_within_timeframe",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "exclusion",
                            "expected_value": [
                                "diagnostic procedures such as laparoscopy",
                                "endoscopic ultrasound",
                                "stenting",
                                "PEG/PEJ placement"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Clinical or laboratory evidence of pancreatitis, based on discretion of treating physician.",
            "criterions": [
                {
                    "exact_snippets": "Clinical or laboratory evidence of pancreatitis",
                    "criterion": "pancreatitis",
                    "requirements": [
                        {
                            "requirement_type": "evidence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "based on discretion of treating physician",
                    "criterion": "treating physician discretion",
                    "requirements": [
                        {
                            "requirement_type": "approval",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [
        {
            "line": "* Positive serologic test for Hepatitis B or C at baseline.",
            "criterions": [
                {
                    "exact_snippets": "Positive serologic test for Hepatitis B ... at baseline.",
                    "criterion": "Hepatitis B serologic test",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "positive"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at baseline"
                        }
                    ]
                },
                {
                    "exact_snippets": "Positive serologic test for ... Hepatitis C at baseline.",
                    "criterion": "Hepatitis C serologic test",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "positive"
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "at baseline"
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}